Novo Nordisk A/S

Danemark


 
Quantité totale PI 2 250
Quantité totale incluant filiales 2 250 (+ 0 pour les filiales)
Rang # Quantité totale PI 576
Note d'activité PI 3,7/5.0    1 105
Rang # Activité PI 666
Symbole boursier
ISIN DK0062498333
Capitalisation 3.5T  (DKK)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

633 118
53 96
1 011 189
150
 
Dernier brevet 2025 - Anti il-6 domain antibodies
Premier brevet 1975 - 4-phenylpiperidine compounds
Dernière marque 2025 - AM Biologics Filling
Première marque 1976 - MIXTARD

Filiales

2 subsidiaries with IP (0 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Custom manufacturing of scientific products, medical products, chemicals, biochemical, and pharma...
P/S Recorded computer software for predicting medical treatment effects.. Promotion via a website, of...
P/S Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medica...
P/S Downloadable software in the nature of mobile applications for the treatment of medical condition...
2024 Invention Glp-1 receptor agonists in dementia. The present invention relates to improved medical therapies...
Invention Enrichment of nkx6.1 and c-peptide co-expressing cells derived in vitro from stem cells. The pre...
P/S Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight...
P/S Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weigh...
P/S Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight...
Invention Site directed mutagenesis of trem-1 antibodies for decreasing viscosity. Antibodies that are cap...
Invention Anti il-6 domain antibodies. The present invention relates to compounds (e.g. ISVDs, polypeptide...
Invention Anti il-6 domain antibodies. The present invention relates to compounds (e.g. ISVDs, polypeptides...
Invention Sortilin-1 binders, constructs and uses thereof. A polypeptide comprising a binder, the binder ha...
Invention Insulin containing pharmaceutical compositions. The present invention is in the field of pharmac...
P/S Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease,...
Invention Semaglutide in medical therapy. The present invention relates to semaglutide for use in weight m...
P/S Pharmaceutical preparations for the treatment of diabetes.
P/S Pharmaceutical preparations for the treatment of diabetes.
Invention Stable semaglutide compositions and uses thereof. The present invention relates to pharmaceutica...
Invention Highly potent isvd compounds capable of substituting for fviii(a). The present invention provide...
Invention Systems and methods for providing titration dose guidance. A method for providing a titration ins...
P/S Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.
P/S Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases.
Invention Procoagulant antibodies. The present invention relates to improved procoagulant antibodies inclu...
Invention Fusion compounds and uses thereof. The invention relates to fusion proteins comprising a GLP-1 p...
Invention Automatic injection device with a top release mechanism. The present invention relates to a hand...
Invention Pharmaceutical compositions of insulin derivatives. The present invention relates to a compositio...
P/S Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease...
Invention Enhancing neuronal differentiation of neural progenitor cells. The present invention relates to a...
Invention Semaglutide in medical therapy. The present invention is directed to use of the GLP-1 receptor ag...
Invention Pharmaceutical formulations of an amylin receptor agonist and a glp-1 receptor agonist comprising...
Invention Combination therapy for treatment of liver disease. The present disclosure relates to a method o...
Invention Process for the preparation of insulin-zinc complexes. The invention concerns a process for prep...
Invention Shielded needle unit with actuatable release feature. A drug delivery assembly comprising a drug ...
Invention Shielded needle unit with rotating needle. A drug delivery assembly comprising a drug-filled cart...
Invention Shielded needle unit with actuatable mounting feature. A drug delivery assembly comprising a drug...
Invention Shielded needle unit with actuatable container coupling. A needle assembly comprising a needle un...
Invention Drug delivery assembly with double-dose prevention. A drug delivery assembly comprises a drug del...
Invention Shielded needle unit with axial mounting feature. A drug delivery assembly comprising a drug deli...
Invention Long-acting growth hormone receptor antagonist and use thereof. The invention relates to a long-a...
Invention Glucose sensitive insulin derivatives. The present invention relates to novel insulin derivatives...
Invention Compositions and methods for inhibiting ketohexokinase (khk). Oligonucleotides are provided here...
P/S Pharmaceutical preparations for the treatment of liver diseases.
P/S Pharmaceutical preparations for the treatment of liver diseases..
Invention Fusion compounds and uses thereof. The invention relates to fusion proteins comprising a GLP-1 po...
Invention Biological methods. The invention relates to a method of identifying one or more caudal ventral m...
Invention Lumen insertable capsule. 1. A drug delivery device (100) comprising: a) a drug chamber (B) confi...
Invention Sensor assembly with identifier determination. A system comprising RGB and UV light emitting mean...
Invention Compositions and methods for inhibiting transmembrane serine protease 6 (tmprss6) expression. Ol...
2022 Invention Tetrahydropyridazines, compositions comprising them and uses thereof. The present document relat...
Invention Photochemical approach to c-terminal a-amidation. The present invention relates to a photochemic...
Invention Device for administering a pharmaceutical suspension. The present invention provides a dose deli...
Invention Ingestible device. An ingestible device may include one or more deployable limbs configured to o...
Invention Tablet comprising a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention relates to...
Invention Sodium n-(8-(2- hydroxybenzoyl)amino)caprylate polymorphic form a. The present invention relates...
Invention Method for providing a cell population enriched in neurons and precursors thereof. The present i...
Invention Injection device
Invention Drug delivery device for delivering a predefined fixed dose. A drug delivery device (100, 300) f...
Invention Medical device with fluid acivated actuation mechanism. A capsule device (100), comprising: a) a...
2021 Invention Compositions and methods for site-directed mutagenesis. The present disclosure provides improved...
Invention Selective delivery of oligonucleotides to glial cells. The present disclosure relates to oligonu...
Invention Capsule administering assembly. A capsule administering assembly (100, 100′) comprising an inges...
2020 Invention Pill bottle